 | • レポートコード：GIR-107A12795 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、標識ペプチドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。標識ペプチドの種類別市場規模（（Arg）9、FAMラベル、（Arg）9、TAMRAラベル、その他）、用途別市場規模（タンパク質化学、免疫、組織化学、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・標識ペプチドの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pepscan、JPT Peptide Technologies、PEPTIDE INSTITUTE、Merck、BIOSYNTAN GmbH、LifeTein、Eurogentec ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：（Arg）9、FAMラベル、（Arg）9、TAMRAラベル、その他 ・用途別分析2016年-2026年：タンパク質化学、免疫、組織化学、その他 ・標識ペプチドの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・標識ペプチドのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・標識ペプチドのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・標識ペプチドの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・標識ペプチドの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Labeled Peptides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Labeled Peptides size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Labeled Peptides market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Labeled Peptides market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
(Arg)9, FAM-labeled
(Arg)9, TAMRA-labeled
Others
Market segment by Application can be divided into
Protein Chemistry
Immunology
Histochemistry
Others
The key market players for global Labeled Peptides market are listed below:
Pepscan
JPT Peptide Technologies
PEPTIDE INSTITUTE
Merck
BIOSYNTAN GmbH
LifeTein
Eurogentec
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Labeled Peptides product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Labeled Peptides, with price, sales, revenue and global market share of Labeled Peptides from 2019 to 2021.
Chapter 3, the Labeled Peptides competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Labeled Peptides breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Labeled Peptides market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Labeled Peptides sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Labeled Peptides Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Labeled Peptides Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 (Arg)9, FAM-labeled
1.2.3 (Arg)9, TAMRA-labeled
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Labeled Peptides Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Protein Chemistry
1.3.3 Immunology
1.3.4 Histochemistry
1.3.5 Others
1.4 Global Labeled Peptides Market Size & Forecast
1.4.1 Global Labeled Peptides Sales in Value (2016-2026))
1.4.2 Global Labeled Peptides Sales in Volume (2016-2026)
1.4.3 Global Labeled Peptides Price by Type (2016-2026) & (US$/Unit)
1.5 Global Labeled Peptides Production Capacity Analysis
1.5.1 Global Labeled Peptides Total Production Capacity (2016-2026)
1.5.2 Global Labeled Peptides Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Labeled Peptides Market Drivers
1.6.2 Labeled Peptides Market Restraints
1.6.3 Labeled Peptides Trends Analysis
2 Manufacturers Profiles
2.1 Pepscan
2.1.1 Pepscan Details
2.1.2 Pepscan Major Business
2.1.3 Pepscan Labeled Peptides Product and Services
2.1.4 Pepscan Labeled Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 JPT Peptide Technologies
2.2.1 JPT Peptide Technologies Details
2.2.2 JPT Peptide Technologies Major Business
2.2.3 JPT Peptide Technologies Labeled Peptides Product and Services
2.2.4 JPT Peptide Technologies Labeled Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 PEPTIDE INSTITUTE
2.3.1 PEPTIDE INSTITUTE Details
2.3.2 PEPTIDE INSTITUTE Major Business
2.3.3 PEPTIDE INSTITUTE Labeled Peptides Product and Services
2.3.4 PEPTIDE INSTITUTE Labeled Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Labeled Peptides Product and Services
2.4.4 Merck Labeled Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 BIOSYNTAN GmbH
2.5.1 BIOSYNTAN GmbH Details
2.5.2 BIOSYNTAN GmbH Major Business
2.5.3 BIOSYNTAN GmbH Labeled Peptides Product and Services
2.5.4 BIOSYNTAN GmbH Labeled Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 LifeTein
2.6.1 LifeTein Details
2.6.2 LifeTein Major Business
2.6.3 LifeTein Labeled Peptides Product and Services
2.6.4 LifeTein Labeled Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Eurogentec
2.7.1 Eurogentec Details
2.7.2 Eurogentec Major Business
2.7.3 Eurogentec Labeled Peptides Product and Services
2.7.4 Eurogentec Labeled Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Labeled Peptides Sales by Manufacturer
3.1 Global Labeled Peptides Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Labeled Peptides Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Labeled Peptides
3.4 Market Concentration Rate
3.4.1 Top 3 Labeled Peptides Manufacturer Market Share
3.4.2 Top 6 Labeled Peptides Manufacturer Market Share
3.5 Global Labeled Peptides Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Labeled Peptides Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Labeled Peptides Market Size by Region
4.1.1 Global Labeled Peptides Sales in Volume by Region (2016-2026)
4.1.2 Global Labeled Peptides Revenue by Region (2016-2026)
4.2 North America Labeled Peptides Revenue (2016-2026)
4.3 Europe Labeled Peptides Revenue (2016-2026)
4.4 Asia-Pacific Labeled Peptides Revenue (2016-2026)
4.5 South America Labeled Peptides Revenue (2016-2026)
4.6 Middle East and Africa Labeled Peptides Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Labeled Peptides Sales in Volume by Type (2016-2026)
5.2 Global Labeled Peptides Revenue by Type (2016-2026)
5.3 Global Labeled Peptides Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Labeled Peptides Sales in Volume by Application (2016-2026)
6.2 Global Labeled Peptides Revenue by Application (2016-2026)
6.3 Global Labeled Peptides Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Labeled Peptides Sales by Type (2016-2026)
7.2 North America Labeled Peptides Sales by Application (2016-2026)
7.3 North America Labeled Peptides Market Size by Country
7.3.1 North America Labeled Peptides Sales in Volume by Country (2016-2026)
7.3.2 North America Labeled Peptides Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Labeled Peptides Sales by Type (2016-2026)
8.2 Europe Labeled Peptides Sales by Application (2016-2026)
8.3 Europe Labeled Peptides Market Size by Country
8.3.1 Europe Labeled Peptides Sales in Volume by Country (2016-2026)
8.3.2 Europe Labeled Peptides Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Labeled Peptides Sales by Type (2016-2026)
9.2 Asia-Pacific Labeled Peptides Sales by Application (2016-2026)
9.3 Asia-Pacific Labeled Peptides Market Size by Region
9.3.1 Asia-Pacific Labeled Peptides Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Labeled Peptides Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Labeled Peptides Sales by Type (2016-2026)
10.2 South America Labeled Peptides Sales by Application (2016-2026)
10.3 South America Labeled Peptides Market Size by Country
10.3.1 South America Labeled Peptides Sales in Volume by Country (2016-2026)
10.3.2 South America Labeled Peptides Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Labeled Peptides Sales by Type (2016-2026)
11.2 Middle East & Africa Labeled Peptides Sales by Application (2016-2026)
11.3 Middle East & Africa Labeled Peptides Market Size by Country
11.3.1 Middle East & Africa Labeled Peptides Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Labeled Peptides Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Labeled Peptides Typical Distributors
12.3 Labeled Peptides Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Labeled Peptides Revenue by Type, (USD Million), 2021-2026
Table 2. Global Labeled Peptides Revenue by Application, (USD Million), 2021-2026
Table 3. Pepscan Basic Information, Manufacturing Base and Competitors
Table 4. Pepscan Major Business
Table 5. Pepscan Labeled Peptides Product and Services
Table 6. Pepscan Labeled Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. JPT Peptide Technologies Basic Information, Manufacturing Base and Competitors
Table 8. JPT Peptide Technologies Major Business
Table 9. JPT Peptide Technologies Labeled Peptides Product and Services
Table 10. JPT Peptide Technologies Labeled Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. PEPTIDE INSTITUTE Basic Information, Manufacturing Base and Competitors
Table 12. PEPTIDE INSTITUTE Major Business
Table 13. PEPTIDE INSTITUTE Labeled Peptides Product and Services
Table 14. PEPTIDE INSTITUTE Labeled Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Labeled Peptides Product and Services
Table 18. Merck Labeled Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. BIOSYNTAN GmbH Basic Information, Manufacturing Base and Competitors
Table 20. BIOSYNTAN GmbH Major Business
Table 21. BIOSYNTAN GmbH Labeled Peptides Product and Services
Table 22. BIOSYNTAN GmbH Labeled Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. LifeTein Basic Information, Manufacturing Base and Competitors
Table 24. LifeTein Major Business
Table 25. LifeTein Labeled Peptides Product and Services
Table 26. LifeTein Labeled Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Eurogentec Basic Information, Manufacturing Base and Competitors
Table 28. Eurogentec Major Business
Table 29. Eurogentec Labeled Peptides Product and Services
Table 30. Eurogentec Labeled Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Labeled Peptides Sales by Manufacturer (2019-2021e) & (K Units)
Table 32. Global Labeled Peptides Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Labeled Peptides, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Labeled Peptides Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Labeled Peptides Production Site of Key Manufacturer
Table 36. Labeled Peptides New Entrant and Capacity Expansion Plans
Table 37. Labeled Peptides Mergers & Acquisitions in the Past Five Years
Table 38. Global Labeled Peptides Sales by Region (2016-2021e) & (K Units)
Table 39. Global Labeled Peptides Sales by Region (2021-2026) & (K Units)
Table 40. Global Labeled Peptides Revenue by Region (2016-2021e) & (USD Million)
Table 41. Global Labeled Peptides Revenue by Region (2021-2026) & (USD Million)
Table 42. Global Labeled Peptides Sales by Type (2016-2021e) & (K Units)
Table 43. Global Labeled Peptides Sales by Type (2021-2026) & (K Units)
Table 44. Global Labeled Peptides Revenue by Type (2016-2021e) & (USD Million)
Table 45. Global Labeled Peptides Revenue by Type (2021-2026) & (USD Million)
Table 46. Global Labeled Peptides Price by Type (2016-2021e) & (US$/Unit)
Table 47. Global Labeled Peptides Price by Type (2021-2026) & (US$/Unit)
Table 48. Global Labeled Peptides Sales by Application (2016-2021e) & (K Units)
Table 49. Global Labeled Peptides Sales by Application (2021-2026) & (K Units)
Table 50. Global Labeled Peptides Revenue by Application (2016-2021e) & (USD Million)
Table 51. Global Labeled Peptides Revenue by Application (2021-2026) & (USD Million)
Table 52. Global Labeled Peptides Price by Application (2016-2021e) & (US$/Unit)
Table 53. Global Labeled Peptides Price by Application (2021-2026) & (US$/Unit)
Table 54. North America Labeled Peptides Sales by Country (2016-2021e) & (K Units)
Table 55. North America Labeled Peptides Sales by Country (2021-2026) & (K Units)
Table 56. North America Labeled Peptides Revenue by Country (2016-2021e) & (USD Million)
Table 57. North America Labeled Peptides Revenue by Country (2021-2026) & (USD Million)
Table 58. North America Labeled Peptides Sales by Type (2016-2021e) & (K Units)
Table 59. North America Labeled Peptides Sales by Type (2021-2026) & (K Units)
Table 60. North America Labeled Peptides Sales by Application (2016-2021e) & (K Units)
Table 61. North America Labeled Peptides Sales by Application (2021-2026) & (K Units)
Table 62. Europe Labeled Peptides Sales by Country (2016-2021e) & (K Units)
Table 63. Europe Labeled Peptides Sales by Country (2021-2026) & (K Units)
Table 64. Europe Labeled Peptides Revenue by Country (2016-2021e) & (USD Million)
Table 65. Europe Labeled Peptides Revenue by Country (2021-2026) & (USD Million)
Table 66. Europe Labeled Peptides Sales by Type (2016-2021e) & (K Units)
Table 67. Europe Labeled Peptides Sales by Type (2021-2026) & (K Units)
Table 68. Europe Labeled Peptides Sales by Application (2016-2021e) & (K Units)
Table 69. Europe Labeled Peptides Sales by Application (2021-2026) & (K Units)
Table 70. Asia-Pacific Labeled Peptides Sales by Region (2016-2021e) & (K Units)
Table 71. Asia-Pacific Labeled Peptides Sales by Region (2021-2026) & (K Units)
Table 72. Asia-Pacific Labeled Peptides Revenue by Region (2016-2021e) & (USD Million)
Table 73. Asia-Pacific Labeled Peptides Revenue by Region (2021-2026) & (USD Million)
Table 74. Asia-Pacific Labeled Peptides Sales by Type (2016-2021e) & (K Units)
Table 75. Asia-Pacific Labeled Peptides Sales by Type (2021-2026) & (K Units)
Table 76. Asia-Pacific Labeled Peptides Sales by Application (2016-2021e) & (K Units)
Table 77. Asia-Pacific Labeled Peptides Sales by Application (2021-2026) & (K Units)
Table 78. South America Labeled Peptides Sales by Country (2016-2021e) & (K Units)
Table 79. South America Labeled Peptides Sales by Country (2021-2026) & (K Units)
Table 80. South America Labeled Peptides Revenue by Country (2016-2021e) & (USD Million)
Table 81. South America Labeled Peptides Revenue by Country (2021-2026) & (USD Million)
Table 82. South America Labeled Peptides Sales by Type (2016-2021e) & (K Units)
Table 83. South America Labeled Peptides Sales by Type (2021-2026) & (K Units)
Table 84. South America Labeled Peptides Sales by Application (2016-2021e) & (K Units)
Table 85. South America Labeled Peptides Sales by Application (2021-2026) & (K Units)
Table 86. Middle East & Africa Labeled Peptides Sales by Country (2016-2021e) & (K Units)
Table 87. Middle East & Africa Labeled Peptides Sales by Country (2021-2026) & (K Units)
Table 88. Middle East & Africa Labeled Peptides Revenue by Country (2016-2021e) & (USD Million)
Table 89. Middle East & Africa Labeled Peptides Revenue by Country (2021-2026) & (USD Million)
Table 90. Middle East & Africa Labeled Peptides Sales by Type (2016-2021e) & (K Units)
Table 91. Middle East & Africa Labeled Peptides Sales by Type (2021-2026) & (K Units)
Table 92. Middle East & Africa Labeled Peptides Sales by Application (2016-2021e) & (K Units)
Table 93. Middle East & Africa Labeled Peptides Sales by Application (2021-2026) & (K Units)
Table 94. Direct Channel Pros & Cons
Table 95. Indirect Channel Pros & Cons
Table 96. Labeled Peptides Typical Distributors
Table 97. Labeled Peptides Typical Customers
List of Figures
Figure 1. Labeled Peptides Picture
Figure 2. Global Labeled Peptides Sales Market Share by Type in 2020
Figure 3. (Arg)9, FAM-labeled
Figure 4. (Arg)9, TAMRA-labeled
Figure 5. Others
Figure 6. Global Labeled Peptides Sales Market Share by Application in 2020
Figure 7. Protein Chemistry
Figure 8. Immunology
Figure 9. Histochemistry
Figure 10. Others
Figure 11. Global Labeled Peptides Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Labeled Peptides Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Labeled Peptides Sales (2016-2026) & (K Units)
Figure 14. Global Labeled Peptides Price by Type (2016-2026) & (US$/Unit)
Figure 15. Global Labeled Peptides Production Capacity (2016-2026) & (K Units)
Figure 16. Global Labeled Peptides Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Labeled Peptides Market Drivers
Figure 18. Labeled Peptides Market Restraints
Figure 19. Labeled Peptides Market Trends
Figure 20. Global Labeled Peptides Sales Market Share by Manufacturer in 2020
Figure 21. Global Labeled Peptides Revenue Market Share by Manufacturer in 2020
Figure 22. Labeled Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Labeled Peptides Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Labeled Peptides Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Labeled Peptides Sales Market Share by Region (2016-2026)
Figure 26. Global Labeled Peptides Revenue Market Share by Region (2016-2026)
Figure 27. North America Labeled Peptides Revenue (2016-2026) & (USD Million)
Figure 28. Europe Labeled Peptides Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Labeled Peptides Revenue (2016-2026) & (USD Million)
Figure 30. South America Labeled Peptides Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Labeled Peptides Revenue (2016-2026) & (USD Million)
Figure 32. Global Labeled Peptides Sales Market Share by Type (2016-2026)
Figure 33. Global Labeled Peptides Revenue Market Share by Type (2016-2026)
Figure 34. Global Labeled Peptides Price by Type (2016-2026) & (US$/Unit)
Figure 35. Global Labeled Peptides Sales Market Share by Application (2016-2026)
Figure 36. Global Labeled Peptides Revenue Market Share by Application (2016-2026)
Figure 37. Global Labeled Peptides Price by Application (2016-2026) & (US$/Unit)
Figure 38. North America Labeled Peptides Sales Market Share by Type (2016-2026)
Figure 39. North America Labeled Peptides Sales Market Share by Application (2016-2026)
Figure 40. North America Labeled Peptides Sales Market Share by Country (2016-2026)
Figure 41. North America Labeled Peptides Revenue Market Share by Country (2016-2026)
Figure 42. United States Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Labeled Peptides Sales Market Share by Type (2016-2026)
Figure 46. Europe Labeled Peptides Sales Market Share by Application (2016-2026)
Figure 47. Europe Labeled Peptides Sales Market Share by Country (2016-2026)
Figure 48. Europe Labeled Peptides Revenue Market Share by Country (2016-2026)
Figure 49. Germany Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Labeled Peptides Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Labeled Peptides Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Labeled Peptides Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Labeled Peptides Revenue Market Share by Region (2016-2026)
Figure 58. China Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Labeled Peptides Sales Market Share by Type (2016-2026)
Figure 65. South America Labeled Peptides Sales Market Share by Application (2016-2026)
Figure 66. South America Labeled Peptides Sales Market Share by Country (2016-2026)
Figure 67. South America Labeled Peptides Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Labeled Peptides Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Labeled Peptides Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Labeled Peptides Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Labeled Peptides Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Labeled Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界の重水素標識化合物市場 2021：企業別、地域別、種類・用途別 The Deuterium Labeled Compounds market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…- 世界の微生物抗菌ペプチド市場 2021：企業別、地域別、種類・用途別 The Microbial Antimicrobial Peptides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界の抗菌ペプチド入り動物飼料市場 2021：企業別、地域別、種類・用途別 The Animal Feed with Antimicrobial Peptides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界の植物抗菌ペプチド市場 2021：企業別、地域別、種類・用途別 The Plant Antimicrobial Peptides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界のアミロイドペプチド市場 2021：企業別、地域別、種類・用途別 The Amyloid Peptides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…